Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Vardenafil Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,146Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Respira to Present Clinical Data on RT234-PAH Patient-Controlled Treatment
    Respira to Present Clinical Data on RT234-PAH Patient-Controlled Treatment

    16 Oct 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/respira-to-present-clinical-data-on-rt234-pah-patient-controlled-treatment-to-acutely-improve-episodic-symptoms-in-pulmonary-arterial-hypertension-pah-patients-301153901.html

    PRNEWSWIRE
    16 Oct 2020
    Share Share
    Alembic Pharms Generic Vardenafil Hydrochloride Receives Approval in US
    Alembic Pharms Generic Vardenafil Hydrochloride Receives Approval in US

    05 Aug 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214031

    FDA
    05 Aug 2020
    Share Share
    Alembic Pharmaceuticals gets USFDA nod for erectile dysfunction drug
    Alembic Pharmaceuticals gets USFDA nod for erectile dysfunction drug

    04 Aug 2020

    // MONEYCONTROL

    https://www.moneycontrol.com/news/business/alembic-pharmaceuticals-gets-usfda-nod-for-erectile-dysfunction-drug-5648221.html

    MONEYCONTROL
    04 Aug 2020
    Share Share
    Determination That LEVITRA (Vardenafil Hydrochloride) Tablets, 2.5 Milligrams
    Determination That LEVITRA (Vardenafil Hydrochloride) Tablets, 2.5 Milligrams

    12 Aug 2019

    // FEDERALREGISTER

    https://www.federalregister.gov/documents/2019/08/12/2019-17212/determination-that-levitra-vardenafil-hydrochloride-tablets-25-milligrams-were-not-withdrawn-from

    FEDERALREGISTER
    12 Aug 2019
    Share Share
    FDA hands back Adamis’ application for an ED drug, looking for more data
    FDA hands back Adamis’ application for an ED drug, looking for more data

    27 Feb 2019

    // Natalie Grover ENDPTS

    https://endpts.com/adamis-erectile-dysfunction-treatment-hits-regulatory-snag-as-fda-calls-marketing-application-incomplete/

    Natalie Grover ENDPTS
    27 Feb 2019
    Share Share
    Alembic Pharm ' Generic Vardenafil Hydrochloride Receives Approval in US
    Alembic Pharm ' Generic Vardenafil Hydrochloride Receives Approval in US

    22 Nov 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208324

    FDA
    22 Nov 2018
    Share Share